The UK life sciences sector is backed by world-class science, £520 million in government commitments, and new private market infrastructure. So why is 94% of late-stage capital still coming from overseas?

In the world of private capital, trust is the foundation. LPs trust GPs to act in their best interest, and GPs trust LPs to be long-term partners. Reputation is what makes or breaks this dynamic.

Learn why trust, perception, and reputation are now more critical than financial returns for both LPs and GPs in fundraising and partnerships. Discover how to build and manage trust as a strategic asset.